Journal article

Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas

Ashleigh M Fordham, Paul G Ekert, Emmy DG Fleuren

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | ELSEVIER | Published : 2021

Abstract

Rapid advances in genomic technologies have enabled in-depth interrogation of cancer genomes, revealing novel and unexpected therapeutic targets in many cancer types. Identifying actionable dependencies in the diverse and heterogeneous group of sarcomas, particularly those that occur in children or adolescents and young adults (AYAs), remains especially challenging. These patients rarely harbor actionable genomic aberrations, no targeted agent is approved, and outcomes have remained poor for the past decades. This underlines a clear need to refine our methods for target identification. Phosphoproteomics studies in sarcoma showed the power of such analyses to capture novel actionable drivers ..

View full abstract